Skip to content
Recall Observatory FDA recall evidence

Drug product

Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only. GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108. UPC: 0-03-0766-1480-30-2.

D-1247-2014

February 20, 2014

Class III

Product summary

Firm
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Event
Event 67800
Status
Terminated
Classification
Class III
Quantity
150 cases
Official record key
drug-enforcement:D-1247-2014

Official wording

Reason: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Code information: Lot #13L05N, Expiry: 8/15

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    superpotent